About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CRY - CryoLife| Previous Close | $17.37 | Open | $17.15 |
| Volume | 200.2K | Market Cap | 1.066B |
| Yield | Last Dividend |
| Surgical Sealants and Adhesives Market T... | 10/26/20 |
| Adhesives and sealants are used during surgical procedures to reinforce surgical wounds, repair injured tissues, or even replace common suturing techn... | |
| CryoLife Announces Release Date and Tele... | 10/21/20 |
| ATLANTA, Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| Surgical Sealants and Adhesives Market: ... | 10/20/20 |
| The growth of the surgical sealants and adhesives market is driven by rise in geriatric population and increase in awareness towards the potential ben... | |
| Tissue Regeneration Market Future Scope ... | 10/14/20 |
| The market insights gained through this Tissue Regeneration Market research analysis report facilitates more defined understanding of the market lands... | |
| CryoLife to Participate in Upcoming Virt... | 08/06/20 |
| ATLANTA, Aug. 6, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced ... | |
| CryoLife Reports Second Quarter 2020 Fin... | 07/30/20 |
| ATLANTA, July 30, 2020 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2... | |
| CryoLife Announces Release Date and Tele... | 07/21/20 |
| ATLANTA, July 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| CryoLife Announces Pricing of $100 Milli... | 06/19/20 |
| ATLANTA, June 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focuse... | |
| CryoLife Announces Offering of Convertib... | 06/18/20 |
| ATLANTA , June 18, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY ) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focu... | |
| Insights on the Worldwide Surgical Seala... | 06/11/20 |
| DUBLIN--(BUSINESS WIRE)--The "Surgical Sealant and Adhesives Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAn... | |
| COVID-19 Impact and Recovery Analysis- A... | 06/10/20 |
| Technavio has been monitoring the aortic stent grafts market and it is poised to grow by USD 690.09 million during 2020-2024, progressing at a CAGR of... | |
| Global Structural Heart Disease Treatmen... | 06/03/20 |
| Technavio has been monitoring the global structural heart disease treatment devices market size and it is poised to grow by USD 5.61 billion during 20... | |
| CryoLife (CRY) Reports Q1 Loss, Tops Rev... | 04/30/20 |
| CryoLife (CRY) delivered earnings and revenue surprises of -500.00% and 1.26%, respectively, for the quarter ended March 2020. Do the numbers hold clu... | |
| CryoLife Reports First Quarter 2020 Fina... | 04/30/20 |
| ATLANTA, April 30, 2020 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 20... | |
| CryoLife Receives CE Mark for On-X?? Asc... | 02/27/20 |
| ATLANTA, Feb. 27, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| CryoLife Reports Fourth Quarter and Full... | 02/13/20 |
| ATLANTA, Feb. 13, 2020 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Total revenues were $69.7 million in the fourth quarter of 2019,... | |
| CryoLife Announces Release Date and Tele... | 01/30/20 |
| ATLANTA, Jan. 30, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced... | |
| CryoLife and Misonix Enter Into Distribu... | 12/19/19 |
| ATLANTA, Dec. 19, 2019 /PRNewswire/ -- CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic diseas... | |
| Is Cryolife Inc (CRY) Going To Burn Thes... | 12/16/19 |
| Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings... | |
| CryoLife Receives CE Mark for E-nya Thor... | 12/02/19 |
| ATLANTA, Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced ... | |
| CryoLife Receives CE Mark for E-nside Th... | 12/02/19 |
| ATLANTA, Dec. 2, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced ... | |
| CryoLife Reports Third Quarter 2019 Fina... | 10/30/19 |
| ATLANTA, Oct. 30, 2019 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, r... | |
| Best Medical Equipment Stock Buy Now: Cr... | 09/23/19 |
| Experienced investment professionals who may be better informed than you now believe CryoLife, Inc. (CRY) to be the industry???s best near-term (3-mon... | |
| CryoLife Enters Agreement With Endospan ... | 09/13/19 |
| CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system. | |
| CryoLife Enters Agreement With Endospan ... | 09/13/19 |
| CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system. | |
| CryoLife (CRY) Surpasses Q2 Earnings and... | 07/30/19 |
| CryoLife (CRY) delivered earnings and revenue surprises of 37.50% and 0.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues ... | |
| Analysts Estimate CryoLife (CRY) to Repo... | 07/23/19 |
| CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| CryoLife (CRY) Q1 2019 Earnings Call Tra... | 04/30/19 |
| CRY earnings call for the period ending March 31, 2019. | |
| CryoLife's (CRY) CEO Patrick Mackin on Q... | 04/30/19 |
| No summary available. | |
| CryoLife EPS in-line, beats on revenue | 04/30/19 |
| No summary available. | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swingers Corner | Akemi Mokoto | 42.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
